Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 146 of 1,261
  1. US 11857575

    Mesenchymal stem cell-derived exosomes and their uses

    Takeda Pharmaceutical Company Limited · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  2. US 11857550

    Benzathine analogs

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  3. US 11859016

    Peptide having cytoprotective effect against environmental pollutant and use thereof

    CAREGEN CO., LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  4. US 11857543

    Compositions and methods for treating anemia

    Akebia Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  5. US 11857535

    Methods of treating mutant lymphomas

    Kymera Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  6. US 11857701

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  7. US 11858931

    Amino acid compounds with unbranched linkers and methods of use

    Pliant Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  8. US 11859190

    Methods and compositions for regulation of transgene expression

    Sangamo Therapeutics, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  9. US 11859185

    Glucokinase (GCK) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  10. US 11857531

    Combination mast cell inhibition for treatment of BPH/LUTS

    Northwestern University · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  11. US 11859021

    Compounds for regulating trained immunity, and their methods of use

    Trained Therapeutix Discovery, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  12. US 11857343

    Microneedle fabrication and device implantation

    The Regents of the University of California · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  13. US 11857528

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  14. US 11859180

    Antisense oligonucleotide compositions

    Ionis Pharmaceuticals, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  15. US 11858970

    Chili pepper seed isolated oligopeptide FTLE and application thereof in preventing or treating cancer

    China Agricultural University · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  16. US 11858930

    Fused bicyclic RAF inhibitors and methods for use thereof

    Jazz Pharmaceuticals Ireland Limited · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  17. US 11858937

    Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors

    Lead Discovery Center GmbH · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  18. US 11858941

    Heterocyclic and heteroaryl compounds for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  19. US 11859020

    Insulin like growth factor binding protein bioactive peptide fragments

    Northwestern University · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  20. US 11858932

    Methods and compositions for treating polycystic ovary syndrome

    SPRUCE BIOSCIENCES, INC. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  21. US 11859234

    Method of monitoring RNase L activity

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  22. US 11858956

    6-aza-nucleoside prodrugs as antiviral agents for treating virus infections

    The Board of Regents of the University of Texas System · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  23. US 11858957

    Ectonucleotidase inhibitors and methods of use thereof

    ANTENGENE THERAPEUTICS LIMITED · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  24. US 11858953

    Compositions and methods for synthesis of phosphorylated molecules

    The Regents of the University of California · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.